Control lens
DeviceDaily disposable multifocal soft lens with 2 add design (2ADD) for 2 weeks
NCT Number: NCT05579886
The objective of the study was to adapt existing multifocal soft lens wearers to a Control Lens for at least 2 weeks and then evaluate the success of switching them to the Test Lens, with a review after 2 weeks.
Looking for future studies?
Notify Me42 year and older
All sexes
Interventional
Not applicable
Coan Eye Care & Optical Boutique, Ocoee, Florida, United States
This prospective, bilateral eye, open label, non-randomized study compared the performance of 2 different designs of daily disposable multifocal contact lenses.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
A person was eligible for inclusion in the study if he/she:
Exclusion criteria
A person was excluded from the study if he/she:
Daily disposable multifocal soft lens with 2 add design (2ADD) for 2 weeks
Daily disposable multifocal soft lens with 3 add design (3ADD) for 2 weeks
Time frame: 2 weeks
Subjective rating measured on a scale of 0-10, 0.5 steps, where 0=Painful, 10=Can't feel the lenses.
CooperVision, Inc.
Industry
Evaluating the Success of Refitting Lens Wearers With MyDay Multifocal, Who Are Already Adapted to Clariti 1Day Multifocal 2-Add Design
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07723716
Eye Diseases, Presbyopia
Seoul, South Korea
View Trial DetailsNCT05646719
Eye Diseases, Presbyopia
Phoenix, Arizona, United States
View Trial DetailsNCT07076160
Eye Diseases, Presbyopia
Jacksonville, Florida, United States
View Trial DetailsNCT07570602
Eye Diseases, Presbyopia
Bloomington, Indiana, United States
View Trial Details